Frequency of Familial Mediterranean Fever Gene Mutation in Patients Presenting With Joint Pain and Diagnosed With

Ufuk U Gullu1, İsmail Balaban2, Soner Sertan Kara3

  • 1Pediatric Cardiology, Hatay Mustafa Kemal University, Hatay, TUR.

Cureus
|September 6, 2023
PubMed

Insights

Familial Mediterranean fever (FMF) gene mutations were investigated in acute rheumatic fever (ARF) patients. No significant difference was found, suggesting ARF patients need FMF evaluation to prevent complications.

Area of Science:

  • Rheumatology
  • Genetics
  • Internal Medicine

Background:

  • Acute rheumatic fever (ARF) is an inflammatory disease following Group A streptococcal infection.
  • Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder caused by MEFV gene mutations.
  • Both ARF and FMF are prevalent in Turkey and share overlapping symptoms, complicating diagnosis.

Purpose of the Study:

  • To determine the frequency of MEFV gene mutations in Turkish patients diagnosed with ARF.
  • To identify potential overlapping conditions between ARF and FMF in this population.

Main Methods:

  • Retrospective screening of ARF patients diagnosed between May 2015 and May 2018.
  • Inclusion of patients who underwent MEFV gene analysis for differential diagnosis of FMF.

Main Results:

  • No statistically significant difference was observed in the presence of MEFV gene mutations among ARF patients.
  • The study found no statistical correlation between MEFV mutations and carditis, elevated ASO levels, or specific arthritis types (monoarthritis, polyarthritis, polyarthralgia).

Conclusions:

  • The findings suggest that MEFV gene mutations do not significantly differ in ARF patients compared to the general population.
  • It is recommended that patients diagnosed with ARF undergo evaluation for FMF to prevent irreversible organ damage, particularly in high-prevalence regions like Turkey.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
16
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
33
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K